SAMHSA recently released a new advisory on digital therapeutics for management and treatment in behavioral health. This advisory “...introduces readers to digital therapeutics (DTx) and the benefits of their use in behavioral health” and “...describes the research, regulatory, and reimbursement implications for DTx as well as selection and implementation considerations.” Cont.
top of page
Search
bottom of page
Comentarios